This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, S. A.
Right arrow Articles by Pieper, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, S. A.
Right arrow Articles by Pieper, R. O.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Oct 1997, 5813-5822, Vol 17, No. 10
Copyright © 1997, American Society for Microbiology

Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome- like positioning

SA Patel, DM Graunke and RO Pieper
Program in Molecular Biology and Division of Hematology/Oncology, Loyola University Chicago, Maywood, Illinois 60153, USA.

Tumor-associated aberrant silencing of CpG island-containing genes has been correlated with increased cytosine methylation, a "closed" chromatin structure, and exclusion of transcription factor binding in the CpG island/promoter regions of affected genes. Given the lack of understanding of what constitutes a closed chromatin structure in CpG islands, however, it has been difficult to assess the relationship among cytosine methylation, chromatin structure, and inappropriate gene silencing. In this study, nuclease accessibility analysis was used to more clearly define the chromatin structure in the CpG island of the human O6-methylguanine DNA methyltransferase (MGMT) gene. Chromatin structure was then related to in vivo DNA-protein interactions and cytosine methylation status of the MGMT CpG island in human glioma cells varying in MGMT expression. The results of these studies indicated that the "open" chromatin structure associated with the MGMT CpG island in MGMT+ cells consisted of an approximately 250-bp transcription factor-binding, nuclease-accessible, nucleosome-free region of DNA, whose formation was associated with at least four flanking, precisely positioned nucleosome-like structures. In MGMT- cells, this precise nucleosomal array was lost and was replaced by randomly positioned nucleosomes (i.e., the closed chromatin structure), regardless of whether methylation of the CpG island was spread over the entire island or limited to regions outside the transcription factor binding region. These results suggest that CpG islands facilitate the expression of housekeeping genes by facilitating nucleosomal positioning and that the conditions that alter the formation of this array (such as perhaps methylation) may indirectly affect CpG island- containing gene expression.


This article has been cited by other articles:

  • Kapoor-Vazirani, P., Kagey, J. D., Powell, D. R., Vertino, P. M. (2008). Role of hMOF-Dependent Histone H4 Lysine 16 Acetylation in the Maintenance of TMS1/ASC Gene Activity. Cancer Res. 68: 6810-6821 [Abstract] [Full Text]  
  • Lavon, I., Fuchs, D., Zrihan, D., Efroni, G., Zelikovitch, B., Fellig, Y., Siegal, T. (2007). Novel Mechanism whereby Nuclear Factor {kappa}B Mediates DNA Damage Repair through Regulation of O6-Methylguanine-DNA-Methyltransferase. Cancer Res. 67: 8952-8959 [Abstract] [Full Text]  
  • Fatemi, M., Pao, M. M., Jeong, S., Gal-Yam, E. N., Egger, G., Weisenberger, D. J., Jones, P. A. (2005). Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 33: e176-e176 [Abstract] [Full Text]  
  • Halford, S, Rowan, A, Sawyer, E, Talbot, I, Tomlinson, I (2005). O6-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions. Gut 54: 797-802 [Abstract] [Full Text]  
  • Zhao, W., Soejima, H., Higashimoto, K., Nakagawachi, T., Urano, T., Kudo, S., Matsukura, S., Matsuo, S., Joh, K., Mukai, T. (2005). The Essential Role of Histone H3 Lys9 Di-Methylation and MeCP2 Binding in MGMT Silencing with Poor DNA Methylation of the Promoter CpG Island. J Biochem 137: 431-440 [Abstract] [Full Text]  
  • Chan, Q. K.Y., Khoo, U.-S., Chan, K. Y.K., Ngan, H. Y.S., Li, S.-S., Chiu, P.-M., Man, L.-S., Ip, P. P.C., Xue, W.-C., Cheung, A. N.Y. (2005). Promoter Methylation and Differential Expression of {pi}-Class Glutathione S-Transferase in Endometrial Carcinoma. J. Mol. Diagn. 7: 8-16 [Abstract] [Full Text]  
  • HERMAN, J.G. (2005). Epigenetic Changes in Cancer and Preneoplasia. Cold Spring Harb Symp Quant Biol 70: 329-333 [Abstract]  
  • Danam, R. P., Howell, S. R., Brent, T. P., Harris, L. C. (2005). Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Molecular Cancer Therapeutics 4: 61-69 [Abstract] [Full Text]  
  • Margison, G. P., Povey, A. C., Kaina, B., Santibanez Koref, M. F. (2003). Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24: 625-635 [Abstract] [Full Text]  
  • Ballestar, E., Esteller, M. (2002). The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23: 1103-1109 [Abstract] [Full Text]  
  • Virmani, A. K., Tsou, J. A., Siegmund, K. D., Shen, L. Y. C., Long, T. I., Laird, P. W., Gazdar, A. F., Laird-Offringa, I. A. (2002). Hierarchical Clustering of Lung Cancer Cell Lines Using DNA Methylation Markers. Cancer Epidemiol. Biomarkers Prev. 11: 291-297 [Abstract] [Full Text]  
  • Chen, C., Yang, T. P. (2001). Nucleosomes Are Translationally Positioned on the Active Allele and Rotationally Positioned on the Inactive Allele of the HPRT Promoter. Mol. Cell. Biol. 21: 7682-7695 [Abstract] [Full Text]  
  • Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L. F., Chang, C., Choon, A., Reznikoff, C. R., Bova, G. S., Friedl, A., Jarrard, D. F. (2000). Methylation of the Androgen Receptor Minimal Promoter Silences Transcription in Human Prostate Cancer. Cancer Res. 60: 3623-3630 [Abstract] [Full Text]  
  • Bearzatto, A., Szadkowski, M., Macpherson, P., Jiricny, J., Karran, P. (2000). Epigenetic Regulation of the MGMT and hMSH6 DNA Repair Genes in Cells Resistant to Methylating Agents. Cancer Res. 60: 3262-3270 [Abstract] [Full Text]  
  • Pogribny, I. P., Pogribna, M., Christman, J. K., James, S. J. (2000). Single-Site Methylation within the p53 Promoter Region Reduces Gene Expression in a Reporter Gene Construct: Possible in Vivo Relevance during Tumorigenesis. Cancer Res. 60: 588-594 [Abstract] [Full Text]  
  • Mucha, M., Lisowska, K., Goc, A., Filipski, J. (2000). Nuclease-hypersensitive Chromatin Formed by a CpG Island in Human DNA Cloned as an Artificial Chromosome in Yeast. J. Biol. Chem. 275: 1275-1278 [Abstract] [Full Text]  
  • Graunke, D. M., Fornace, A. J. Jr, Pieper, R. O. (1999). Presetting of chromatin structure and transcription factor binding poise the human GADD45 gene for rapid transcriptional up-regulation. Nucleic Acids Res 27: 3881-3890 [Abstract] [Full Text]  
  • Eileen Dolan, M., L. McRae, B., Ferries-Rowe, E., Belanich, M., van Seventer, G. A., Guitart, J., Pezen, D., Kuzel, T. M., Yarosh, D. B. (1999). O6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents. Clin. Cancer Res. 5: 2059-2064 [Abstract] [Full Text]  
  • Millar, D. S., Paul, C. L., Molloy, P. L., Clark, S. J. (2000). A Distinct Sequence (ATAAA)n Separates Methylated and Unmethylated Domains at the 5'-End of the GSTP1 CpG Island*. J. Biol. Chem. 275: 24893-24899 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»